Reduced Intensity Conditioning: Clinical Trials

4 trials of Reduced Intensity Conditioning, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed, 1 recruiting, 1 unknown. 4 Phase 1, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 14Completed 2, Recruiting 1, Unknown 1
Phase 21Unknown 1

Follow Reduced Intensity Conditioning: new trials by email Literature Review of Reduced Intensity Conditioning trials Research Report on Reduced Intensity Conditioning

Trials (filtered) newest first · largest first

All 4 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Ruxolitinib With Azacitidine Maintenance for the Treatment of Patients With Acute Myeloid Leukemia Undergoing Reduced Intensity Allogeneic Stem Cell Transplantation
Allogeneic Hematopoietic Stem Cell Transplantation, Azacitidine, Biospecimen Collection - Acute Myeloid Leukemia
Phase 1RecruitingOHSU Knight Cancer Institute402026-04-212026-10-05
Haploidentical Hematopoietic Stem Cell Transplantation
peripheral blood stem cell graft that are CD34+ selected - Sickle Cell-thalassemia Disease, Thalassemia
Phase 1CompletedCatherine Bollard72015-01-012024-12-19
Immunotherapy Following Reduced Intensity Conditioning and Allogeneic Stem Cell Transplant for Poor Risk CD30+ Hodgkin Lymphoma Patients
Brentuximab Vedotin, Allogeneic Stem Cell Transplantation, Reduced Intensity Conditioning - Hodgkin Lymphoma
Phase 1 / Phase 2UnknownNew York Medical College202014-03-012022-10-27
Reduced Intensity Conditioning for Umbilical Cord Blood Transplant in Pediatric Patients With Non-Malignant Disorders
Unrelated Umbilical Cord Blood Transplant, Reduced Intensity Conditioning - Non Malignant Disorders, Immunodeficiencies
Phase 1CompletedDuke University222008-10-012014-08-13

Conditions studied

Thalassemia (2)  ·  Anemia, Diamond-Blackfan (1)  ·  Hemoglobinopathies (1)  ·  Hodgkin Disease (1)  ·  Immunologic Deficiency Syndromes (1)  ·  Leukemia, Myeloid, Acute (1)  ·  Lysosomal Storage Diseases (1)  ·  Metabolism, Inborn Errors (1)  ·  Mucopolysaccharidosis I (1)  ·  Mucopolysaccharidosis II (1)  ·  Severe Combined Immunodeficiency (1)

Sponsors

Catherine Bollard (1)  ·  Duke University (1)  ·  New York Medical College (1)  ·  OHSU Knight Cancer Institute (1)

Countries

United States (4)

Top investigators

Jennifer N Saultz (1)  ·  Mitchell Cairo, MD (1)  ·  Suhag Parikh, MD (1)

Results publications

PMID 24296492, PMID 36240296